You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced ovarian cancer

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Trial in Fuzhou (Fluzopari and apatinib)

Not yet recruiting
  • Ovarian Cancer
  • Fluzopari and apatinib
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Oct 25, 2022

Recurrent Ovarian Cancer, Recurrent Uterine Cancer, Metastatic Cancer Trial in Toronto (RP-6306, Carboplatin, Paclitaxel)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Oct 25, 2023

Ovarian Cancer Trial in Belgium, Germany (IMAB027)

Completed
  • Ovarian Cancer
  • Brussels, Belgium
  • +8 more
Nov 7, 2021

High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (Sovilnesib)

Not yet recruiting
  • High Grade Serous Adenocarcinoma of Ovary
  • +3 more
  • (no location specified)
Oct 13, 2023

Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

Recruiting
  • Advanced Pancreatic Carcinoma
  • +27 more
  • Gainesville, Florida
  • +3 more
Jan 3, 2023

Breast Cancer Female, Ovarian Cancer, Gastric Cancer Trial in Bronx (Nivolumab, Ipilimumab)

Terminated
  • Breast Cancer Female
  • +2 more
  • Nivolumab
  • Ipilimumab
  • Bronx, New York
    Hoffman Oncology
Nov 5, 2021

Ovarian Cancer Trial (JPI-547)

Not yet recruiting
  • Ovarian Cancer
  • (no location specified)
Jul 24, 2022

Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or

Recruiting
  • Ovarian Cancer
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Jul 13, 2022

    Renal Cell Carcinoma, Urothelial Carcinoma, Cervical Cancer Trial in Shanghai (SHR-1210, Famitinib)

    Recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Shanghai, Shanghai, China
      Huadong Hospital Affiliated to Fudan University
    Jun 30, 2022

    Locally Advanced Cervical Carcinoma, Premature Ovarian Failure Trial in São Paulo (Ovarian graft)

    Recruiting
    • Locally Advanced Cervical Carcinoma
    • Premature Ovarian Failure
    • Ovarian graft
    • São Paulo, Brazil
      Instituto do Cancer do Estado de São Paulo
    Jul 29, 2022

    Ovarian Cancer, Endometrial Cancer, Cervix Cancer Trial in Oklahoma City (SHetA2)

    Recruiting
    • Ovarian Cancer
    • +2 more
    • Oklahoma City, Oklahoma
      Stephenson Cancer Center
    Jul 7, 2022

    Ovarian Cancer Trial in Pittsburgh (Carboplatin AUC 5 and paclitaxel, Bintrafusp alfa (M7824))

    Not yet recruiting
    • Ovarian Cancer
    • Carboplatin AUC 5 and paclitaxel
    • Bintrafusp alfa (M7824)
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Medical Center
    Jul 12, 2022

    Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial (HS-10502)

    Not yet recruiting
    • Ovarian Cancer
    • +4 more
    • (no location specified)
    Feb 24, 2023

    Advanced Solid Tumor, Platinum-Resistant Ovarian Cancer, Platinum-Resistant Urothelial Carcinoma Trial in Darlinghurst, Kogarah,

    Terminated
    • Advanced Solid Tumor
    • +3 more
    • Darlinghurst, New South Wales, Australia
    • +1 more
    Dec 18, 2022

    Ovarian Tumors Trial in United States (Niraparib, Bevacizumab)

    Active, not recruiting
    Has Results
    • Ovarian Neoplasms
    • Mobile, Alabama
    • +27 more
    Nov 23, 2022

    Advanced Ovarian Cancer Trial in Fujian (SC10914)

    Unknown status
    • Advanced Ovarian Cancer
    • Fujian, China
      Fujian Cancer Hospital
    May 11, 2021

    Ovarian Cancer Trial in Hungary, United Kingdom, United States (EP0057, Olaparib tablets)

    Recruiting
    • Ovarian Cancer
    • Lady Lake, Florida
    • +15 more
    Mar 29, 2022

    Bespoke ctDNA Assay for Recurrence and Treatment Response

    Recruiting
    • Ovarian Cancer
    • platinum-sensitive EOC
    • platinum-resistant and rEOC
    • Shanghai, Shanghai, China
      Hao Wen
    Jul 5, 2022

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Locally Advanced Solid Tumor Trial in New Brunswick, New York (Laboratory Biomarker

    Recruiting
    • BRCA1 Gene Mutation
    • +19 more
    • Laboratory Biomarker Analysis
    • Pembrolizumab
    • New Brunswick, New Jersey
    • +1 more
    Nov 16, 2022

    Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma, Metastatic Malignant Solid Tumor Trial (BET Bromodomain Inhibitor

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +7 more
    • Atlanta, Georgia
    • +2 more
    Nov 3, 2022

    FIGO Stage III and IV Ovarian Cancer, FIGO Stage III and IV Fallopian Tube Cancer, FIGO Stage III Primary Peritoneal Cancer

    Completed
    • FIGO Stage III and IV Ovarian Cancer
    • +2 more
    • ALT-803 Subcutaneous
    • ALT-803 Intraperitoneal
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Oct 5, 2022

    Epithelial Carcinoma, Ovarian, Neoadjuvant Chemo Trial in Chendu (cisplatin i.p.)

    Recruiting
    • Epithelial Carcinoma, Ovarian
    • Neoadjuvant Chemotherapy
    • cisplatin i.p.
    • Chendu, Sichuan, China
      West China Second University Hospital of Sichuan University
    Aug 3, 2021

    Advanced Solid Tumor, Advanced Cancer, Advanced Carcinoma Trial (AMT-151)

    Not yet recruiting
    • Advanced Solid Tumor
    • +18 more
    • (no location specified)
    Aug 10, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (3 cycles chemo instead of 6 cycles chemo, 6 cycles

    Not yet recruiting
    • Ovarian Cancer
    • +3 more
    • 3 cycles chemotherapy instead of 6 cycles chemotherapy
    • 6 cycles chemotherapy
    • (no location specified)
    Jul 12, 2022

    Breast Cancer and Ovarian Cancer Trial (SPARC-08-038, Ref-08-038)

    Completed
    • Breast Cancer and Ovarian Cancer
    • (no location specified)
    Jul 22, 2021